Cargando…
Fixed drug eruption after Pfizer-BioNTech COVID-19 vaccine: A case report
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Academy of Allergy, Asthma & Immunology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023364/ https://www.ncbi.nlm.nih.gov/pubmed/35470099 http://dx.doi.org/10.1016/j.jaip.2022.03.033 |
| _version_ | 1784690331352039424 |
|---|---|
| author | Lellig, Elodie Mouton-Faivre, Claudie Abs, Diane Bursztejn, Anne-Claire |
| author_facet | Lellig, Elodie Mouton-Faivre, Claudie Abs, Diane Bursztejn, Anne-Claire |
| author_sort | Lellig, Elodie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9023364 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Academy of Allergy, Asthma & Immunology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90233642022-04-22 Fixed drug eruption after Pfizer-BioNTech COVID-19 vaccine: A case report Lellig, Elodie Mouton-Faivre, Claudie Abs, Diane Bursztejn, Anne-Claire J Allergy Clin Immunol Pract Clinical Communication American Academy of Allergy, Asthma & Immunology 2022-07 2022-04-22 /pmc/articles/PMC9023364/ /pubmed/35470099 http://dx.doi.org/10.1016/j.jaip.2022.03.033 Text en © 2022 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Clinical Communication Lellig, Elodie Mouton-Faivre, Claudie Abs, Diane Bursztejn, Anne-Claire Fixed drug eruption after Pfizer-BioNTech COVID-19 vaccine: A case report |
| title | Fixed drug eruption after Pfizer-BioNTech COVID-19 vaccine: A case report |
| title_full | Fixed drug eruption after Pfizer-BioNTech COVID-19 vaccine: A case report |
| title_fullStr | Fixed drug eruption after Pfizer-BioNTech COVID-19 vaccine: A case report |
| title_full_unstemmed | Fixed drug eruption after Pfizer-BioNTech COVID-19 vaccine: A case report |
| title_short | Fixed drug eruption after Pfizer-BioNTech COVID-19 vaccine: A case report |
| title_sort | fixed drug eruption after pfizer-biontech covid-19 vaccine: a case report |
| topic | Clinical Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023364/ https://www.ncbi.nlm.nih.gov/pubmed/35470099 http://dx.doi.org/10.1016/j.jaip.2022.03.033 |
| work_keys_str_mv | AT lelligelodie fixeddrugeruptionafterpfizerbiontechcovid19vaccineacasereport AT moutonfaivreclaudie fixeddrugeruptionafterpfizerbiontechcovid19vaccineacasereport AT absdiane fixeddrugeruptionafterpfizerbiontechcovid19vaccineacasereport AT bursztejnanneclaire fixeddrugeruptionafterpfizerbiontechcovid19vaccineacasereport |